PTGS2 and cancer: Ahmed A. H. Abdellatif et al., indicated that delivery of celecoxib (CXB) using transethosomes have lower cytotoxic effect on normal skin cells and significantly increased drug concentration in the skin, so that by inhibiting cyclooxygenase-2 (COX-2) resulted in the reducing cell growth and induction of apoptosis in cancer cells [100].